Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38 participants
OBSERVATIONAL
2011-01-31
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Vascular function is assessed by flow-mediated dilation oft he brachial artery, forearm blood flow and laser doppler perfusion imaging.
We hypothesize that hypoxemia leads to impaired vascular function.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CAD patients with COPD
No interventions assigned to this group
CAD patients without COPD
No interventions assigned to this group
healthy volunteers
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stable chronic obstructive pulmonary disease
Exclusion Criteria
* acute exacerbated COPD within 30 days
* acute infections
* severe acute or chronic renal failure
* severe heart failure
* atrial fibrillation
* severe cardiac arrhythmia
* hypotension
* active malignant disease
* active rheumatic disease
* pulmonary hypertension with vasoactive therapy
40 Years
80 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinik für Kardiologie, Pneumologie und Angiologie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klinik für Kardiologie, Pneumologie und Angiologie
Division of Cardiology, Pulmonary Diseases, Vascular Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Heiss, MD
Role: PRINCIPAL_INVESTIGATOR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Malte Kelm, MD
Role: STUDY_CHAIR
Division of Cardiology, Pulmonary Disease and Vascular Medicineine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COPD_pO2
Identifier Type: -
Identifier Source: org_study_id